116
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics in Patients with Redetected Positive RNA Test After Recovery from Foreign-Imported COVID-19 Cases in Xi’an, China

, , , , , & ORCID Icon show all
Pages 3295-3307 | Published online: 24 Jun 2022

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
  • World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int. Accessed March 5, 2022.
  • Parra LM, Cantero M, Morras I, et al. Hospital readmissions of discharged patients with COVID-19. Int J Gen Med. 2020;13:1359–1366. doi:10.2147/IJGM.S275775
  • Liu XH, Lu SH, Chen J, et al. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China. Emerg Microbes Infect. 2020;9(1):1230–1232. doi:10.1080/22221751.2020.1766383
  • Leung K, Shum MH, Leung GM, Lam TT, Wu JT. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill. 2021;26(1):2002106.
  • Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854):438–443. doi:10.1038/s41586-021-03402-9
  • Wells CR, Sah P, Moghadas SM, et al. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proc Natl Acad Sci USA. 2020;117(13):7504–7509. doi:10.1073/pnas.2002616117
  • Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468
  • Hoehl S, Rabenau H, Berger A, et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med. 2020;382(13):1278–1280. doi:10.1056/NEJMc2001899
  • Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020;323(15):1502–1503. doi:10.1001/jama.2020.2783
  • Yuan B, Liu HQ, Yang ZR, et al. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep. 2020;10(1):11887. doi:10.1038/s41598-020-68782-w
  • Huang K, Liu W, Zhou J, et al. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation. Int J Med Sci. 2021;18(12):2545–2550. doi:10.7150/ijms.58766
  • Gao C, Zhu L, Jin CC, Tong YX, Xiao AT, Zhang S. Prevalence and impact factors of recurrent positive SARS-CoV-2 detection in 599 hospitalized COVID-19 patients. Clin Microbiol Infect. 2021;27(5):785.e781–787.e781. doi:10.1016/j.cmi.2021.01.028
  • An J, Liao X, Xiao T, et al. Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test. Ann Transl Med. 2020;8(17):1084. doi:10.21037/atm-20-5602
  • Wei PF; National Health Commission & State Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (8th ed). Chin Med J. 2021;133(9):1087–1095.
  • Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol. 2020;92(10):1755–1756. doi:10.1002/jmv.25855
  • Xu K, Chen Y, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71(15):799–806. doi:10.1093/cid/ciaa351
  • Zou Y, Wang BR, Sun L, et al. The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China. J Infect Dis. 2020;222(11):1784–1788. doi:10.1093/infdis/jiaa301
  • Hong LX, Liu L, Lin A, Yan WH. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge. Int Immunopharmacol. 2021;95:107579. doi:10.1016/j.intimp.2021.107579
  • Yi W, Long X, Liu J, et al. Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study. Hum Cell. 2021;34(6):1744–1754. doi:10.1007/s13577-021-00618-9
  • Wong CL, Lei SK, Lei CI, Lo IL, Lam C, Leong IH. Re-positive of SARS-CoV-2 test is common in COVID-19 patients after hospital discharge. Data from high standard post-discharge quarantined patients in Macao SAR, China. PeerJ. 2021;9:e11170. doi:10.7717/peerj.11170
  • Váncsa S, Dembrovszky F, Farkas N, et al. Repeated SARS-CoV-2 positivity: analysis of 123 cases. Viruses. 2021;13(3):512. doi:10.3390/v13030512
  • Zhou J, Zhang J, Zhou J, et al. Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: a retrospective cohort study. PLoS One. 2020;15(11):e0241896. doi:10.1371/journal.pone.0241896
  • Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–665. doi:10.1016/j.jinf.2020.03.041
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Ziadi A, Hachimi A, Admou B, et al. Lymphopenia in critically ill COVID-19 patients: a predictor factor of severity and mortality. Int J Lab Hematol. 2021;43(1):e38–e40. doi:10.1111/ijlh.13351
  • Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847. doi:10.1002/ajh.25829
  • Yang Z, Chen X, Huang R, et al. Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission. BMC Infect Dis. 2021;21(1):127. doi:10.1186/s12879-020-05751-8
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
  • Shi D, Wu W, Wang Q, et al. Clinical characteristics and factors associated with long-term viral excretion in patients with severe acute respiratory syndrome coronavirus 2 infection: a single-center 28-day study. J Infect Dis. 2020;222(6):910–918. doi:10.1093/infdis/jiaa388
  • Yang C, Jiang M, Wang X, et al. Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study. Emerg Microbes Infect. 2020;9(1):2368–2378. doi:10.1080/22221751.2020.1837018
  • Findings from investigation and analysis of re-positive cases. Available from: https://www.cdc.go.kr/board/boardes?mid=a30402000000&bid=0030. Accessed June 20, 2022.
  • Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–1494. doi:10.1001/jama.2020.3204
  • Li D, Wang D, Dong J, et al. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21(4):505–508. doi:10.3348/kjr.2020.0146
  • Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725
  • Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265. doi:10.1002/jmv.26114
  • Kang YJ. South Korea’s COVID-19 infection status: from the perspective of re-positive test results after viral clearance evidenced by negative test results. Disaster Med Public Health Prep. 2020;14(6):762–764. doi:10.1017/dmp.2020.168
  • Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi:10.1001/jama.2020.3786